Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry

Orlando, USA

Thomas J Webster

Thomas J Webster

Northeastern University, USA

Title: Nano medicine for the diagnosis prevention and treatment of wide- ranging clinical conditions


Biography: Thomas J Webster


Problem Statement: Medical conditions that are fully or partially irremediable, and which have the potential to leave patients permanently debilitated, are prevalent, despite the wide clinical availability of therapeutics, drugs, and diagnostic tools. Major contemporary health and well-being risks are onsets by a slew of causative agents, including antibiotic-resistant microorganisms that prompt facilely transmissible infectious diseases; inherited genetic disorders or mutations that maximize the likelihood of certain cancers in affected individuals; and traumatic injuries that result in lifelong localized pain, disfigurement, or surgical intervention. Methodology: Nanotechnological solutions are dependent on the manipulation of elementary constituents to produce particles or features with dimensions on the order of 100nm or less, from extremity-to-extremity, and which display optimal quantum effects and enhanced surface area to volume ratios. Facile synthesis approaches, including nanoparticle self-assembly, hydrothermal production, and biogenic methods, have been adapted to achieve these Nano dimensions in medical systems.
Findings: Unique nanoparticle physiochemical properties, pertaining to size, morphology, and electronic responsiveness contribute to biomolecular impairment and ATP depletion in antagonistic cell types. For instance, noble metal and metal oxide nanoparticles have demonstrated anti-bacterial and anti-cancer efficacy following their application within in-vitro and in-vivo environments. Targeted delivery has been successfully approached through the synthesis of nanocarriers loaded with various drugs, proteins, genetic materials, and fluorescent probes. Nanofibrous or nano featured orthopedic scaffolds with optimal surface energies and mechanical properties have aided in implant optimization. 
Conclusions: Advances in nanotechnology will produce an index of safe and versatile treatments that functionally exceed current regimens or that warrant clinical solutions to otherwise untreatable medical complications or conditions.